Russo L - Search Results

1

The mechanisms of cancer-associated thrombosis.

Falanga A, Marchetti M, Russo L. Falanga A, et al. Among authors: russo l. Thromb Res. 2015 Feb;135 Suppl 1:S8-S11. doi: 10.1016/S0049-3848(15)50432-5. Epub 2015 Feb 9. Thromb Res. 2015. PMID: 25903541 Review.

2

V617F JAK-2 mutation in patients with essential thrombocythemia: relation to platelet, granulocyte, and plasma hemostatic and inflammatory molecules.

Falanga A, Marchetti M, Vignoli A, Balducci D, Russo L, Guerini V, Barbui T. Falanga A, et al. Among authors: russo l. Exp Hematol. 2007 May;35(5):702-11. doi: 10.1016/j.exphem.2007.01.053. Exp Hematol. 2007. PMID: 17577920 Free article.

3

Endothelial capillary tube formation and cell proliferation induced by tumor cells are affected by low molecular weight heparins and unfractionated heparin.

Marchetti M, Vignoli A, Russo L, Balducci D, Pagnoncelli M, Barbui T, Falanga A. Marchetti M, et al. Among authors: russo l. Thromb Res. 2008;121(5):637-45. doi: 10.1016/j.thromres.2007.06.015. Epub 2007 Aug 10. Thromb Res. 2008. PMID: 17692905

4

Procoagulant mechanisms in tumour cells.

Falanga A, Panova-Noeva M, Russo L. Falanga A, et al. Among authors: russo l. Best Pract Res Clin Haematol. 2009 Mar;22(1):49-60. doi: 10.1016/j.beha.2008.12.009. Best Pract Res Clin Haematol. 2009. PMID: 19285272 Review.

5

Acquired and inherited risk factors for developing venous thromboembolism in cancer patients receiving adjuvant chemotherapy: a prospective trial.

Mandalà M, Barni S, Prins M, Labianca R, Tondini C, Russo L, Milesi A, Cremonesi M, Zaccanelli M, Regonesi C, Moro C, Falanga A. Mandalà M, et al. Among authors: russo l. Ann Oncol. 2010 Apr;21(4):871-876. doi: 10.1093/annonc/mdp354. Epub 2009 Aug 27. Ann Oncol. 2010. PMID: 19713246 Free article. Clinical Trial.

6

Nitric oxide derivatives and soluble plasma selectins in patients with myeloproliferative neoplasms.

Cella G, Marchetti M, Vianello F, Panova-Noeva M, Vignoli A, Russo L, Barbui T, Falanga A. Cella G, et al. Among authors: russo l. Thromb Haemost. 2010 Jul;104(1):151-6. doi: 10.1160/TH09-09-0663. Epub 2010 Apr 29. Thromb Haemost. 2010. PMID: 20431848

7

LMWH bemiparin and ULMWH RO-14 reduce the endothelial angiogenic features elicited by leukemia, lung cancer, or breast cancer cells.

Vignoli A, Marchetti M, Russo L, Cantalino E, Diani E, Bonacina G, Falanga A. Vignoli A, et al. Among authors: russo l. Cancer Invest. 2011 Feb;29(2):153-61. doi: 10.3109/07357907.2010.543217. Cancer Invest. 2011. PMID: 21261475

8

Platelet-induced thrombin generation by the calibrated automated thrombogram assay is increased in patients with essential thrombocythemia and polycythemia vera.

Panova-Noeva M, Marchetti M, Spronk HM, Russo L, Diani E, Finazzi G, Salmoiraghi S, Rambaldi A, Barbui T, Ten Cate H, Falanga A. Panova-Noeva M, et al. Among authors: russo l. Am J Hematol. 2011 Apr;86(4):337-42. doi: 10.1002/ajh.21974. Am J Hematol. 2011. PMID: 21442635 Free article.

9

All trans-retinoic acid modulates the procoagulant activity of human breast cancer cells.

Marchetti M, Russo L, Balducci D, Falanga A. Marchetti M, et al. Among authors: russo l. Thromb Res. 2011 Oct;128(4):368-74. doi: 10.1016/j.thromres.2011.03.006. Epub 2011 Apr 1. Thromb Res. 2011. PMID: 21458031

10

JAK2V617F mutation and hydroxyurea treatment as determinants of immature platelet parameters in essential thrombocythemia and polycythemia vera patients.

Panova-Noeva M, Marchetti M, Buoro S, Russo L, Leuzzi A, Finazzi G, Rambaldi A, Ottomano C, Ten Cate H, Falanga A. Panova-Noeva M, et al. Among authors: russo l. Blood. 2011 Sep 1;118(9):2599-601. doi: 10.1182/blood-2011-02-339655. Epub 2011 Jul 12. Blood. 2011. PMID: 21750318 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,241 results

Search Page